Blanchi A - Search Results

Year	Number of Results
1978	1
1981	1
1982	1
1983	2
1984	4
1985	1
1987	1
1988	2
1989	1
1990	1
1991	1
1992	1
1993	3
1994	1
1995	2
1996	1
1997	3
1999	1
2003	1
2005	2
2006	2
2008	2
2009	1
2010	1
2011	1
2012	3
2013	2
2014	1
2015	1
2016	2
2017	2
2018	2
2024	0

1

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators. Aparicio T, et al. Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26. Eur J Cancer. 2018. PMID: 29807237 Free article.

2

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.

Melin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Lang JP, Marcellin P, Cacoub P; CheObs Study Group. Melin P, et al. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1050-7. doi: 10.1097/MEG.0b013e328338d9aa. Eur J Gastroenterol Hepatol. 2010. PMID: 20351554 Free article.

3

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.

Nahon S, Hagège H, Latrive JP, Rosa I, Nalet B, Bour B, Faroux R, Gower P, Arpurt JP, Denis J, Henrion J, Rémy AJ, Pariente A; Groupe des Hémorragies Digestives Hautes de l’ANGH. Nahon S, et al. Endoscopy. 2012 Nov;44(11):998-1008. doi: 10.1055/s-0032-1310006. Epub 2012 Oct 29. Endoscopy. 2012. PMID: 23108771

4

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group. Bourrier A, et al. Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9. Aliment Pharmacol Ther. 2016. PMID: 26549003 Free article.

5

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group. Beaugerie L, et al. Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7. Lancet. 2009. PMID: 19837455

6

Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patients.

Zeitoun JD, Rosa-Hézode I, Chryssostalis A, Nalet B, Bour B, Arpurt JP, Denis J, Nahon S, Pariente A, Hagège H; Groupe des Hémorragies Digestives Hautes de l’ANGH. Zeitoun JD, et al. Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):227-34. doi: 10.1016/j.clinre.2011.11.008. Epub 2012 Feb 3. Clin Res Hepatol Gastroenterol. 2012. PMID: 22306054

7

Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?

Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, Person B, Croue A, Dohn S, Benoit R, Fabiani B, Boyer J. Meyer V, et al. Among authors: blanchi a. Gastrointest Endosc. 1997 Jun;45(6):480-4. doi: 10.1016/s0016-5107(97)70177-9. Gastrointest Endosc. 1997. PMID: 9199904 Clinical Trial.

8

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.

Beaugerie L, Carrat F, Nahon S, Zeitoun JD, Sabaté JM, Peyrin-Biroulet L, Colombel JF, Allez M, Fléjou JF, Kirchgesner J, Svrcek M; Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group. Beaugerie L, et al. Clin Gastroenterol Hepatol. 2018 Jun;16(6):892-899.e2. doi: 10.1016/j.cgh.2017.11.041. Epub 2017 Dec 2. Clin Gastroenterol Hepatol. 2018. PMID: 29199142

9

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group. Sokol H, et al. Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23. Inflamm Bowel Dis. 2012. PMID: 22271569

10

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group. Carrat F, et al. Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19. Aliment Pharmacol Ther. 2017. PMID: 27995656 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year